5′-Deoxy-S-fluorouridine Increases Daunorubicin Uptake in Multidrug-resistant Cells and Its Activity Is Related with P-gp 170 Expression-Reference-Cited by-同舟云学术

5′-Deoxy-S-fluorouridine Increases Daunorubicin Uptake in Multidrug-resistant Cells and Its Activity Is Related with P-gp 170 Expression

Published:1994-01 Issue:1 Volume:85 Page:13-16
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

van der Heyden Sylke,Gheuens Eric,van de Vrie Wim,Van Bockstaele Dirk,Van Oosterom Allan,Eggermont Alexander,De Bruijn Ernst A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1994.tb02880.x/fullpdf

Reference17 articles.

1. Selective activation of 5′-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index;Armstrong;Cancer Res.,1981

2. Activation and cytotoxicity of 5′-deoxy-5-fluorouridine in c-H-ras transformed NIH 3T3 cells;Geng;Biochem. Pharm.,1991

3. Transformation of mouse fibroblasts with H-ras and trk is associated with pronounced changes in drug sensitivity and metabolism. 7th NCI-EORTC Symp;Peters;on New Drugs in Cancer Therapy,1992

4. Pharmacology of 5′-deoxy-5-fluorouridine in patients with resistant ovarian cancer;Bruijn;Cancer Res.,1985

5. A syngeneic in vivo model of a multidrug resistant colon carcinoma, CCS31 in the WAG rat;Vrie;Proc. Am. Assoc. Cancer Res.,1991

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine;Investigational New Drugs;2000

2. Pharmacokinetics and bioavailability of oral 5′-deoxy-5-fluorouridine in cancer patients;British Journal of Clinical Pharmacology;1999-04

3. In VivoModel Systems in P-Glycoprotein-Mediated Multidrug Resistance;Critical Reviews in Clinical Laboratory Sciences;1998-01

4. Circumvention of drug resistance in cancer cells by a new fluoropyrimidine analogue;Experimental & Molecular Medicine;1996-09

5. 763 Continuous low dose, oral doxifluridine (DFURI, 5’-deoxy-5-fluorouridine) for the generation of non-toxic 5FU levels in colorectal cancer;European Journal of Cancer;1995-11